Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 17 Source: Company
- €742 million turnover
-
-€121 million
profit - 2,000 employees
-
31st Dec 16 Source: CRO
- €438 million turnover
-
€147.3 million
profit - 380 employees
- 5 more years available »
Ranking
By Turnover
(€742 million)- 106th in Top Companies
- 17th in Health
- 17th in Pharma
By Employees
(2,000)- 113th in Top Companies
- 18th in Health
- 7th in Pharma
-
- 2,000
- €742 million
Employees
- James Burke Director
Latest News
- May 27 Oaktree founder warns private equity standards slipping
- May 27 Barnier warns Britain to stop playing ‘hide and seek’ on Brexit
- May 27 Vacant site levy faces legal challenge after farmer concession
- May 26 Stripe and Amazon meet Ministers over housing policy
- May 26 Low-key Irish development group abandons Chicago deal